The Front Line of Our Freedom January 11, 2016 • admin • The threat of chemical and biological weapons use against our military and civilian populations is real. Related News Countervail receives additional $845,000 SBIR Fast Track Phase II grant award for continued development of AverTox® (galantamine) for pre-exposure administration to protect against soman toxicity. May 29, 2015 Countervail corporation is awarded $346,000 for phase 1 of fast track SBIR Grant from the National Institutes of Health for studies of nerve gas antidote September 12, 2010
